Matthew T. Chang
Active 2014–2023
- 38
- Papers
- 18,566
- Citations
- 34
- h-index
- 38
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine50.7%
- Biochemistry, Genetics and Molecular Biology45.1%
- Computer Science1.5%
- Immunology and Microbiology1.3%
- Agricultural and Biological Sciences0.3%
- Chemistry0.3%
- Other0.8%
Topics
- Cancer Genomics and Diagnostics9.1%
- Prostate Cancer Treatment and Research4.3%
- Lung Cancer Treatments and Mutations3.8%
- Cancer Immunotherapy and Biomarkers2.7%
- Ubiquitin and proteasome pathways2.1%
- Genetic factors in colorectal cancer2.1%
- Other75.9%
Coauthors
- Barry S. Taylor15
- David B. Solit10
- Alexander Penson8
- Ahmet Zehir7
- Jianjiong Gao7
- Mark T.A. Donoghue7
- Nikolaus Schultz7
- Alexander N. Gorelick6
- Alison M. Schram6
- David M. Hyman6
- Michael F. Berger6
- Philip Jonsson6
- Anwesha Dey5
- Debyani Chakravarty5
- Eva Lin5
- Ritika Kundra5
- Sarat Chandarlapaty5
- Sizhi Paul Gao5
- Bob T. Li4
- Christiaan Klijn4
- Craig M. Bielski4
- Ho-June Lee4
- José Baselga4
- Pedram Razavi4
All papers
- OncoKB: A Precision Oncology Knowledge Base
Authors: Debyani Chakravarty, Jianjiong Gao, Sarah Phillips, Ritika Kundra, Hongxin Zhang, Jiaojiao Wang, Julia E. Rudolph, Rona Yaeger, Tara E. Soumerai, Moriah H. Nissan, Matthew T. Chang, Sarat Chandarlapaty, Tiffany A. Traina, Paul K. Paik, Alan L. Ho, Feras Hantash, Andrew Grupe, Shrujal S. Baxi, Margaret K. Callahan, Alexandra Snyder, Ping Chi, Daniel C. Danila, Mrinal M. Gounder, James J. Harding, Matthew D. Hellmann, Gopa Iyer, Yelena Y. Janjigian, Thomas Kaley, Douglas A. Levine, Maeve A. Lowery, Antonio Omuro, Michael A. Postow, Dana E. Rathkopf, Alexander N. Shoushtari, Neerav Shukla, Martin H. Voss, Ederlinda Paraiso, Ahmet Zehir, Michael F. Berger, Barry S. Taylor, Leonard B. Saltz, Gregory J. Riely, Marc Ladanyi, David M. Hyman, José Baselga, Paul Sabbatini, David B. Solit, Nikolaus Schultz - JCO Precision Oncology 2017 cited by 2,698
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Authors: Ahmet Zehir, Ryma Benayed, Ronak Shah, Aijazuddin Syed, Sumit Middha, Hyunjae R. Kim, Preethi Srinivasan, Jianjiong Gao, Debyani Chakravarty, Sean M. Devlin, Matthew D. Hellmann, David Barron, Alison M. Schram, Meera Hameed, Snjezana Doğan, Dara S. Ross, Jaclyn F. Hechtman, Deborah F. DeLair, JinJuan Yao, Diana Mandelker, Donavan T. Cheng, Raghu Chandramohan, Abhinita Mohanty, Ryan Ptashkin, Gowtham Jayakumaran, Meera Prasad, Mustafa Syed, Anoop Balakrishnan Rema, Zhen Y. Liu, Khédoudja Nafa, Laetitia Borsu, Justyna Sadowska, Jacklyn Casanova, Ruben Bacares, Iwona Kiecka, Anna Razumova, Julie B Son, Lisa Stewart, Tessara Baldi, Kerry Mullaney, Hikmat Al‐Ahmadie, Efsevia Vakiani, Adam Abeshouse, Alexander Penson, Philip Jonsson, Niedzica Camacho, Matthew T. Chang, Helen Won, Benjamin Groß, Ritika Kundra, Zachary Heins, Hsiao‐Wei Chen, Sarah Phillips, Hongxin Zhang, Jiaojiao Wang, Angelica Ochoa, Jonathan Wills, Michael Eubank, Stacy B. Thomas, Stuart M. Gardos, Dalicia N. Reales, Jesse Galle, Robert Durany, Roy Cambria, Wassim Abida, Andrea Cercek, Darren R. Feldman, Mrinal M. Gounder, A. Ari Hakimi, James J. Harding, Gopa Iyer, Yelena Y. Janjigian, Emmet Jordan, Ciara M. Kelly, Maeve A. Lowery, Luc G.T. Morris, Antonio Omuro, Nitya Raj, Pedram Razavi, Alexander N. Shoushtari, Neerav Shukla, Tara E. Soumerai, Anna M. Varghese, Rona Yaeger, Jonathan Coleman, Bernard H. Bochner, Gregory J. Riely, Leonard B. Saltz, Howard I. Scher, Paul Sabbatini, Mark E. Robson, David S. Klimstra, Barry S. Taylor, José Baselga, Nikolaus Schultz, David M. Hyman, Maria E. Arcila, David B. Solit, Marc Ladanyi, Michael F. Berger - Nature Medicine 2017 cited by 3,517
- The Molecular Taxonomy of Primary Prostate Cancer
Authors: Adam Abeshouse, Jaeil Ahn, Rehan Akbani, Adrian Ally, Samirkumar B. Amin, Chris Andry, Matti Annala, Armen Aprikian, Joshua Armenia, Arshi Arora, J. Todd Auman, Miruna Balasundaram, Saianand Balu, Christopher E. Barbieri, Thomas Bauer, Christopher C. Benz, Alain Bergeron, Rameen Beroukhim, Mario Berríos, Adrian Bivol, Tom Bodenheimer, Lori Boice, Moiz S. Bootwalla, Rodolfo Borges dos Reis, Paul C. Boutros, Jay Bowen, Reanne Bowlby, Jeffrey M. Boyd, Robert K. Bradley, Anne Breggia, Fadi Brimo, Christopher A. Bristow, Denise Brooks, Bradley M. Broom, Alan H. Bryce, Glenn J. Bubley, Eric Burks, Yaron S.N. Butterfield, M. Button, David Canes, Carlos Gilberto Carlotti, Rebecca Carlsen, Michel Carmel, Peter R. Carroll, Scott L. Carter, Richard W. Cartun, Brett S. Carver, June M. Chan, Matthew T. Chang, Yu Chen, Andrew D. Cherniack, Simone Chevalier, Lynda Chin, Juok Cho, Andy Chu, Eric Chuah, Sudha Chudamani, Kristian Cibulskis, Giovanni Ciriello, Amanda Clarke, Matthew R. Cooperberg, Niall M. Corcoran, Anthony J. Costello, Janet E. Cowan, Daniel Crain, Erin Curley, Kerstin A. David, John A. Demchok, Francesca Demichelis, Noreen Dhalla, Rajiv Dhir, Alexandre A. Doueik, Bettina F. Drake, Heidi Dvinge, Natalya Dyakova, Ina Felau, Martin L. Ferguson, Scott Frazer, Stephen J. Freedland, Yao Fu, Stacey Gabriel, Jianjiong Gao, Johanna Gardner, Julie M. Gastier-Foster, Nils Gehlenborg, Mark Gerken, Mark Gerstein, Gad Getz, Andrew K. Godwin, Anuradha Gopalan, Markus Graefen, Kiley Graim, Thomas Gribbin, Ranabir Guin, Manaswi Gupta, Angela Hadjipanayis, Syed Haider, Lucie Hamel, D. Neil Hayes, David I. Heiman and 212 more - Cell 2015 cited by 3,279
- The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
Authors: Pedram Razavi, Matthew T. Chang, Guotai Xu, Chaitanya Bandlamudi, Dara S. Ross, Neil Vasan, Yanyan Cai, Craig M. Bielski, Mark T.A. Donoghue, Philip Jonsson, Alexander Penson, Ronglai Shen, Fresia Pareja, Ritika Kundra, Sumit Middha, Michael L. Cheng, Ahmet Zehir, Cyriac Kandoth, Ruchi Patel, Kety Huberman, Lillian M. Smyth, Komal Jhaveri, Shanu Modi, Tiffany A. Traina, Chau T. Dang, Wen Zhang, Britta Weigelt, Bob T. Li, Marc Ladanyi, David M. Hyman, Nikolaus Schultz, Mark E. Robson, Clifford A. Hudis, Edi Brogi, Agnès Viale, Larry Norton, Maura N. Dickler, Michael F. Berger, Christine A. Iacobuzio–Donahue, Sarat Chandarlapaty, Maurizio Scaltriti, Jorge S. Reis‐Filho, David B. Solit, Barry S. Taylor, José Baselga - Cancer Cell 2018 cited by 1,006
- Genome doubling shapes the evolution and prognosis of advanced cancers
Authors: Craig M. Bielski, Ahmet Zehir, Alexander Penson, Mark T.A. Donoghue, Walid K. Chatila, Joshua Armenia, Matthew T. Chang, Alison M. Schram, Philip Jonsson, Chaitanya Bandlamudi, Pedram Razavi, Gopa Iyer, Mark E. Robson, Zsofia K. Stadler, Nikolaus Schultz, José Baselga, David B. Solit, David M. Hyman, Michael F. Berger, Barry S. Taylor - Nature Genetics 2018 cited by 692
- Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma
Authors: A. Gordon Robertson, Juliann Shih, Christina Yau, Ewan A. Gibb, Junna Oba, Karen Mungall, Julian M. Hess, Vladislav Uzunangelov, Vonn Walter, Ludmila Danilova, Tara M. Lichtenberg, Melanie H. Kucherlapati, Patrick K. Kimes, Ming Tang, Alexander Penson, Özgün Babur, Rehan Akbani, Christopher A. Bristow, Katherine A. Hoadley, Lisa Iype, Matthew T. Chang, Mohamed H. Abdel‐Rahman, Rehan Akbani, Adrian Ally, J. Todd Auman, Özgün Babur, Miruna Balasundaram, Saianand Balu, Christopher Benz, Rameen Beroukhim, İnanç Birol, Tom Bodenheimer, Jay Bowen, Reanne Bowlby, Christopher A. Bristow, Denise Brooks, Rebecca Carlsen, Colleen M. Cebulla, Matthew T. Chang, Andrew D. Cherniack, Lynda Chin, Juok Cho, Eric Chuah, Sudha Chudamani, Carrie Cibulskis, Kristian Cibulskis, Leslie Cope, Sarah E. Coupland, Ludmila Danilova, Timothy Defreitas, John A. Demchok, Laurence Desjardins, Noreen Dhalla, Bita Esmaeli, Ina Felau, Martin L. Ferguson, Scott Frazer, Stacey Gabriel, Julie M. Gastier‐Foster, Nils Gehlenborg, Mark Gerken, Jeffrey E. Gershenwald, Gad Getz, Ewan A. Gibb, Klaus Griewank, Elizabeth A. Grimm, D. Neil Hayes, Apurva M. Hegde, David I. Heiman, Carmen Helsel, Julian M. Hess, Katherine A. Hoadley, Shital Hobensack, Robert A. Holt, Alan P. Hoyle, Xin Hu, Carolyn M. Hutter, Martine J. Jager, Stuart R. Jefferys, Corbin D. Jones, Steven J.M. Jones, Cyriac Kandoth, Katayoon Kasaian, Jaegil Kim, Patrick K. Kimes, Melanie Kucherlapati, Raju Kucherlapati, Eric S. Lander, Michael S. Lawrence, Alexander J. Lazar, Semin Lee, Kristen Leraas, Tara M. Lichtenberg, Pei Lin, Jia Liu, Wenbin Liu, Laxmi Lolla, Yiling Lu, Lisa Iype, Yussanne Ma and 111 more - Cancer Cell 2017 cited by 919
- An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance
Authors: Thijs J. Hagenbeek, Jason R. Zbieg, Marc Hafner, Rana Mroue, Jennifer A. Lacap, Nicole M. Sodir, Cameron L. Noland, Shervin Afghani, Ayush Kishore, Kamakoti P. Bhat, Xiaosai Yao, Stephen D. Schmidt, Saundra Clausen, Micah Steffek, Wendy Lee, Paul Beroza, Scott E. Martin, Eva Lin, Rina Fong, Paola Di Lello, Marta H. Kubala, Michelle N.-Y. Yang, Jeffrey Lau, Emily Chan, Alfonso Arrazate, Le An, Elizabeth Levy, Maria Lorenzo, Ho-June Lee, Trang H. Pham, Zora Modrušan, Richard Zang, Yi‐Chen Chen, Michał Kabza, Musaddeque Ahmed, Jason Li, Matthew T. Chang, Danilo Maddalo, Marie Evangelista, Xin Ye, James J. Crawford, Anwesha Dey - Nature Cancer 2023 cited by 195
- Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity
Authors: Matthew T. Chang, Saurabh Asthana, Sizhi Paul Gao, Byron Lee, Jocelyn Chapman, Cyriac Kandoth, Jianjiong Gao, Nicholas D. Socci, David B. Solit, Adam B. Olshen, Nikolaus Schultz, Barry S. Taylor - Nature Biotechnology 2015 cited by 832
- Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS
Authors: Zhan Yao, Rona Yaeger, Vanessa Rodrik-Outmezguine, Anthony Tao, Neilawattie M. Torres, Matthew T. Chang, Matthias Drosten, HuiYong Zhao, Fabiola Cecchi, Todd Hembrough, Judith Michels, Hervé Baumert, Linde A. Miles, Naomi Campbell, Elisa de Stanchina, David B. Solit, Mariano Barbacid, Barry S. Taylor, Neal Rosen - Nature 2017 cited by 562
- Accelerating Discovery of Functional Mutant Alleles in Cancer
Authors: Matthew T. Chang, Tripti Shrestha Bhattarai, Alison M. Schram, Craig M. Bielski, Mark T.A. Donoghue, Philip Jonsson, Debyani Chakravarty, Sarah Phillips, Cyriac Kandoth, Alexander Penson, Alexander N. Gorelick, Tambudzai Shamu, Swati Patel, Christopher Harris, Jianjiong Gao, S. Onur Sumer, Ritika Kundra, Pedram Razavi, Bob T. Li, Dalicia N. Reales, Nicholas D. Socci, Gowtham Jayakumaran, Ahmet Zehir, Ryma Benayed, Maria E. Arcila, Sarat Chandarlapaty, Marc Ladanyi, Nikolaus Schultz, José Baselga, Michael F. Berger, Neal Rosen, David B. Solit, David M. Hyman, Barry S. Taylor - Cancer Discovery 2017 cited by 426
- Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies
Authors: Emmet Jordan, Hyunjae R. Kim, Maria E. Arcila, David Barron, Debyani Chakravarty, Jianjiong Gao, Matthew T. Chang, Ai Ni, Ritika Kundra, Philip Jonsson, Gowtham Jayakumaran, Sizhi Paul Gao, Hannah C. Johnsen, Aphrothiti J. Hanrahan, Ahmet Zehir, Natasha Rekhtman, Michelle S. Ginsberg, Bob T. Li, Helena A. Yu, Paul K. Paik, Alexander Drilon, Matthew D. Hellmann, Dalicia N. Reales, Ryma Benayed, Valerie W. Rusch, Mark G. Kris, Jamie E. Chaft, José Baselga, Barry S. Taylor, Nikolaus Schultz, Charles M. Rudin, David M. Hyman, Michael F. Berger, David B. Solit, Marc Ladanyi, Gregory J. Riely - Cancer Discovery 2017 cited by 662
- Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
Authors: Neil Vasan, Pedram Razavi, Jared L. Johnson, Hong Shao, Hardik Shah, Alesia Antoine, Erik Ladewig, Alexander N. Gorelick, Ting-Yu Lin, Eneda Toska, Guotai Xu, Abiha Kazmi, Matthew T. Chang, Barry S. Taylor, Maura N. Dickler, Komal Jhaveri, Sarat Chandarlapaty, Raúl Rabadán, Ed Reznik, Melissa Smith, Robert Sebra, Frauke Schimmöller, Timothy R. Wilson, Lori S. Friedman, Lewis C. Cantley, Maurizio Scaltriti, José Baselga - Science 2019 cited by 295
- USP7 small-molecule inhibitors interfere with ubiquitin binding
Authors: Lorna Kategaya, Paola Di Lello, Lionel Rougé, Richard Pastor, Kevin Clark, Jason Drummond, Tracy Kleinheinz, Eva Lin, John-Paul Upton, Sumit Prakash, Johanna Heideker, Mark L. McCleland, Maria Stella Ritorto, Dario R. Alessi, Matthias Trost, Travis W. Bainbridge, Michael C. M. Kwok, P. Taylur, Zachary Stiffler, Bradley Brasher, Yinyan Tang, Priyadarshini Jaishankar, Brian R. Hearn, Adam R. Renslo, Michelle R. Arkin, Frederick Cohen, Kebing Yu, Frank Peale, Florian Gnad, Matthew T. Chang, Christiaan Klijn, Elizabeth Blackwood, Scott E. Martin, William F. Forrest, James A. Ernst, Chudi Ndubaku, Xiaojing Wang, Maureen H. Beresini, Vickie Tsui, Carsten Schwerdtfeger, Robert A. Blake, Jeremy Murray, Till Maurer, Ingrid E. Wertz - Nature 2017 cited by 346
- ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma
Authors: Ivana Yen, Frances Shanahan, Jeeyun Lee, Yong Sang Hong, Sang Joon Shin, Amanda R. Moore, Jawahar Sudhamsu, Matthew T. Chang, InHwan Bae, Darlene Dela Cruz, Thomas Hunsaker, Christiaan Klijn, Nicholas P. D. Liau, Eva Lin, Scott E. Martin, Zora Modrušan, Robert Piskol, Ehud Segal, Avinashnarayan Venkatanarayan, Xin Ye, Jianping Yin, Liangxuan Zhang, Jin-Soo Kim, Hyeong-Seok Lim, Kyu-pyo Kim, Yu Jung Kim, Hye Sook Han, Soo Jung Lee, Seung Tae Kim, Minkyu Jung, Yoon-Hee Hong, Young Su Noh, Munjeong Choi, Oakpil Han, Małgorzata Nowicka, Shrividhya Srinivasan, Yibing Yan, Tae Won Kim, Shiva Malek - Nature 2021 cited by 135
- Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance
Authors: Alison M. Schram, Matthew T. Chang, Philip Jonsson, Alexander Drilon - Nature Reviews Clinical Oncology 2017 cited by 328
- AKT Inhibition in Solid Tumors With AKT1 Mutations
Authors: David M. Hyman, Lillian M. Smyth, Mark T.A. Donoghue, Shannon N. Westin, Philippe L. Bédard, Emma Dean, Hideaki Bando, Anthony B. El-Khoueiry, José Alejandro Pérez Fidalgo, Alain C. Mita, Jan H.M. Schellens, Matthew T. Chang, Jonathan Reichel, Nancy Bouvier, S. Duygu Selçuklu, Tara E. Soumerai, Jean Torrisi, Joseph P. Erinjeri, Helen Ambrose, J. Carl Barrett, Brian Dougherty, Andrew Foxley, Justin P.O. Lindemann, Robert McEwen, Martin Pass, Gaia Schiavon, Michael F. Berger, Sarat Chandarlapaty, David B. Solit, Udai Banerji, José Baselga, Barry S. Taylor - Journal of Clinical Oncology 2017 cited by 325
- Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma
Authors: Amanda R. Moore, Emilie Ceraudo, Jessica Sher, Youxin Guan, Alexander N. Shoushtari, Matthew T. Chang, Jenny Q. Zhang, Edward Walczak, Manija A. Kazmi, Barry S. Taylor, Thomas Huber, Ping Chi, Thomas P. Sakmar, Yu Chen - Nature Genetics 2016 cited by 312
- Copy number alteration burden predicts prostate cancer relapse
Authors: Haley Hieronymus, Nikolaus Schultz, Anuradha Gopalan, Brett S. Carver, Matthew T. Chang, Yonghong Xiao, Adriana Heguy, Kety Huberman, Melanie Bernstein, Melissa Assel, Rajmohan Murali, Andrew J. Vickers, Peter T. Scardino, Chris Sander, Victor E. Reuter, Barry S. Taylor, Charles L. Sawyers - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 387
- Targeting MCL‐1 and BCL‐2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non‐Hodgkin lymphoma: Results from preclinical models and a Phase Ib study
Authors: Elisabeth A. Lasater, Dhara N. Amin, Rajat Bannerji, Raghuveer Singh Mali, Kathy Barrett, Ryan N. Rys, Jason Oeh, Eva Lin, Tim Sterne‐Weiler, Ellen Ingalla, MaryAnn Go, Shang‐Fan Yu, Maxwell M. Krem, Chris Arthur, Uwe Hahn, Anna Johnston, Vinit Karur, Nadia Khan, Paula Marlton, Tycel Phillips, Giuseppe Gritti, John F. Seymour, Monica Tani, Sam Yuen, Scott E. Martin, Matthew T. Chang, Christopher M. Rose, Victoria C. Pham, Andrew G. Polson, YiMeng Chang, Claudia M. Wever, Nathalie A. Johnson, Yanwen Jiang, Jamie Hirata, Deepak Sampath, Lisa Musick, Christopher R. Flowers, Ingrid E. Wertz - American Journal of Hematology 2023 cited by 26
- Allele-Specific Mechanisms of Activation of MEK1 Mutants Determine Their Properties
Authors: Yijun Gao, Matthew T. Chang, Daniel J. McKay, Na Na, Bing Zhou, Rona Yaeger, Neilawattie M. Torres, Keven Muniz, Matthias Drosten, Mariano Barbacid, Giordano Caponigro, Darrin D. Stuart, Henrik Moebitz, David B. Solit, Omar Abdel‐Wahab, Barry S. Taylor, Zhan Yao, Neal Rosen - Cancer Discovery 2018 cited by 148
- Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis
Authors: Matthew T. Chang, Alexander Penson, Neil Desai, Nicholas D. Socci, Ronglai Shen, Venkatraman Seshan, Ritika Kundra, Adam Abeshouse, Agnès Viale, Eugene K. Cha, Xueli Hao, Victor E. Reuter, Charles M. Rudin, Bernard H. Bochner, Jonathan E. Rosenberg, Dean F. Bajorin, Nikolaus Schultz, Michael F. Berger, Gopa Iyer, David B. Solit, Hikmat Al‐Ahmadie, Barry S. Taylor - Clinical Cancer Research 2017 cited by 131
- Machine-Learning and Chemicogenomics Approach Defines and Predicts Cross-Talk of Hippo and MAPK Pathways
Authors: Trang H. Pham, Thijs J. Hagenbeek, Ho-June Lee, Jason Li, Christopher M. Rose, Eva Lin, Mamie Yu, Scott E. Martin, Robert Piskol, Jennifer A. Lacap, Deepak Sampath, Victoria C. Pham, Zora Modrušan, Jennie R. Lill, Christiaan Klijn, Shiva Malek, Matthew T. Chang, Anwesha Dey - Cancer Discovery 2020 cited by 63
- 3D clusters of somatic mutations in cancer reveal numerous rare mutations as functional targets
Authors: Jianjiong Gao, Matthew T. Chang, Hannah C. Johnsen, Sizhi Paul Gao, Brooke E. Sylvester, S. Onur Sumer, Hongxin Zhang, David B. Solit, Barry S. Taylor, Nikolaus Schultz, Chris Sander - Genome Medicine 2017 cited by 233
- The Hippo Pathway as a Driver of Select Human Cancers
Authors: Aishwarya Kulkarni, Matthew T. Chang, Joseph H.A. Vissers, Anwesha Dey, Kieran F. Harvey - Trends in cancer 2020 cited by 79
